Stock Events

Stock Events

Atea Pharmaceuticals (AVIR) Q2 2024 Earnings

14MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.75

-0.61

-0.48

-0.34

Details

Expected EPS

-0.52105

Actual EPS

-0.75

Surprise EPS

-0.23

Surprise Percent

+43.94%

Description

Atea Pharmaceuticals (AVIR) has reported earnings of -0.75 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.